Prediction of thrombosis risk in patients with paroxysmal nocturnal hemoglobinuria.


Journal

Annals of hematology
ISSN: 1432-0584
Titre abrégé: Ann Hematol
Pays: Germany
ID NLM: 9107334

Informations de publication

Date de publication:
Oct 2019
Historique:
received: 29 11 2018
accepted: 29 07 2019
pubmed: 10 8 2019
medline: 19 9 2019
entrez: 10 8 2019
Statut: ppublish

Résumé

Paroxysmal nocturnal hemoglobinuria (PNH) is an acquired hemolytic disease with thrombosis as a major complication. The mechanism of thrombosis and related risk factors in PNH patients are still not well characterized. We retrospectively enrolled 99 patients with newly diagnosed PNH at our institute from 2011 to 2016. According to binary logistic regression model analysis, we first identified four baseline clinical risk factors which may be associated with incidence of thrombosis in the PNH cohort, including PNH clone sizes (fluorescent aerolysin of neutrophil) ≤ 80 (OR 1.056, 95%CI 1.016-1.097, P = 0.005), hemoglobin ≤ 75 g/L (OR 4.202, 95%CI 0.984-17.954, P = 0.053), platelet > 100 × 10

Identifiants

pubmed: 31396670
doi: 10.1007/s00277-019-03770-3
pii: 10.1007/s00277-019-03770-3
doi:

Types de publication

Clinical Trial Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2283-2291

Subventions

Organisme : Chinese Academy of Medical Sciences (CN)
ID : 2016-I2M-3-004
Organisme : National Key Research and Development Program (CN)
ID : 2016YFC0901500
Organisme : Beijing Natural Science Foundation
ID : 7192168

Commentaires et corrections

Type : ErratumIn

Auteurs

Yuzhou Huang (Y)

Department of Hematology, Peking Union Hospital, CAMS & PUMC, Beijing, 100730, China.

Xinjian Liu (X)

Department of Hematology, Henan Cancer Hospital, Institute of Hematology of Henan Province, Affiliated Cancer Hospital of Zhengzhou University, 127 Dongming Road, Zhengzhou, China.

Fangfei Chen (F)

Department of Hematology, Peking Union Hospital, CAMS & PUMC, Beijing, 100730, China.

Wenzhe Zhou (W)

Department of Hematology, Peking Union Hospital, CAMS & PUMC, Beijing, 100730, China.

Hongmin Li (H)

Department of Hematology, Peking Union Hospital, CAMS & PUMC, Beijing, 100730, China.

Zhangbiao Long (Z)

Department of Hematology, Peking Union Hospital, CAMS & PUMC, Beijing, 100730, China.

Chen Yang (C)

Department of Hematology, Peking Union Hospital, CAMS & PUMC, Beijing, 100730, China.

Miao Chen (M)

Department of Hematology, Peking Union Hospital, CAMS & PUMC, Beijing, 100730, China.

Bing Han (B)

Department of Hematology, Peking Union Hospital, CAMS & PUMC, Beijing, 100730, China. hanbing_li@sina.com.cn.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH